[ad_1]
|
Listen to this text  |
The ROSA Shoulder System for robot-assisted surgical procedure. | Source: Zimmer Biomet
Zimmer Biomet introduced final week that it obtained FDA 510(okay) clearance for its ROSA Shoulder System, which it claimed is the primary surgical robotic for shoulder substitute. It can be the fourth utility for the Robotic Surgical Assistant, which incorporates the ROSA Knee System for whole knee arthroplasty and the ROSA Hip System for whole hip substitute.
“We are proud and excited to be the first company in the world to deliver a robotic surgical assistant for anatomic and reverse shoulder-replacement surgery,” mentioned Ivan Tornos, president and CEO of Zimmer Biomet, in a launch. “ROSA Shoulder represents a novel advancement intended to help surgeons leverage the power of robotics and data analytics to perform highly complex shoulder procedures with accuracy and efficiency.”
With greater than 90 years of expertise, Zimmer Biomet mentioned it provides an built-in suite of digital and robotic applied sciences that use information, information analytics, and synthetic intelligence. The Warsaw, Ind.-based firm has operations in over 25 nations and gross sales in over 100 nations.
Zimmer Biomet provides to portfolio
Zimmer Biomet mentioned ROSA Shoulder joins its shoulder-implant portfolio, which incorporates the Identity Shoulder System. The robotic additionally joins the ZBEdge Dynamic Intelligence platform, which is meant to reinforce the Zimmer Inc. unit‘s digital applied sciences, robotics, and implants.
The firm mentioned it designed ROSA Shoulder to provide surgeons flexibility and to allow exact placement for improved outcomes. It is likely one of the solely techniques that may reproduce humeral head resectioning, asserted Zimmer Biomet.
ROSA may ease the insertion of devices into incisions by requiring no pin within the middle of the glenoid throughout procedures, it defined.
As with different ROSA purposes, the shoulder system helps information for doctor decision-making based mostly on distinctive anatomies, mentioned Zimmer Biomet. Pre-operatively, it integrates with the newly launched Signature ONE surgical planning system. Signature ONE makes use of a 3D image-based strategy to visualization, surgical planning, and patient-specific information creation.
During the surgical procedure, the platform offers surgeons with real-time, intra-operative information to assist them management, execute, and validate personalised plans for glenoid and humeral placement. Zimmer Biomet mentioned that is in pursuit of the aim of lowering issues for sufferers.
ROSA Shoulder will work with the mymobility Digital Care Management Platform, including to the ZBEdge Dynamic Intelligence portfolio for sufferers present process shoulder-replacement surgical procedure.
ROSA provides Mayo Clinic information earlier than and through surgical procedures
“One of the challenging aspects of performing a shoulder replacement is accurate glenoid and humeral placement, which is a critical factor for post-operative function and long-term implant survival,” said John W. Sperling, M.D., MBA, and a professor of Orthopedic Surgery at Mayo Clinic.
“This innovative approach is designed to allow surgeons to virtually walk through a procedure before making any resections, and then receive live feedback and the ability to control glenoid ream depth and intra-operatively validate cut resections during the procedure,” he mentioned.
Mayo Clinic has a monetary curiosity in Zimmer Biomet’s expertise and mentioned it’ll use any income it receives to help its not-for-profit mission in affected person care, training, and analysis.
Zimmer Biomet mentioned ROSA Shoulder will likely be commercially obtainable within the U.S. within the second half of 2024.
Editor’s notice: This article was syndicated from The Robot Report sibling web site MassDevice.
Learn from Agility Robotics, Amazon, Disney, Teradyne and plenty of extra.